206 related articles for article (PubMed ID: 17548836)
1. Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor.
Ge G; Fernández CA; Moses MA; Greenspan DS
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10010-5. PubMed ID: 17548836
[TBL] [Abstract][Full Text] [Related]
2. Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures.
Uzel MI; Scott IC; Babakhanlou-Chase H; Palamakumbura AH; Pappano WN; Hong HH; Greenspan DS; Trackman PC
J Biol Chem; 2001 Jun; 276(25):22537-43. PubMed ID: 11313359
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance.
Piwnica D; Touraine P; Struman I; Tabruyn S; Bolbach G; Clapp C; Martial JA; Kelly PA; Goffin V
Mol Endocrinol; 2004 Oct; 18(10):2522-42. PubMed ID: 15192082
[TBL] [Abstract][Full Text] [Related]
4. Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases.
Pappano WN; Steiglitz BM; Scott IC; Keene DR; Greenspan DS
Mol Cell Biol; 2003 Jul; 23(13):4428-38. PubMed ID: 12808086
[TBL] [Abstract][Full Text] [Related]
5. BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein.
Ge G; Greenspan DS
J Cell Biol; 2006 Oct; 175(1):111-20. PubMed ID: 17015622
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-1/Tolloid-like proteinases process dentin matrix protein-1.
Steiglitz BM; Ayala M; Narayanan K; George A; Greenspan DS
J Biol Chem; 2004 Jan; 279(2):980-6. PubMed ID: 14578349
[TBL] [Abstract][Full Text] [Related]
7. Developmental roles of the BMP1/TLD metalloproteinases.
Ge G; Greenspan DS
Birth Defects Res C Embryo Today; 2006 Mar; 78(1):47-68. PubMed ID: 16622848
[TBL] [Abstract][Full Text] [Related]
8. The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains.
Wermter C; Höwel M; Hintze V; Bombosch B; Aufenvenne K; Yiallouros I; Stöcker W
Biol Chem; 2007 May; 388(5):513-21. PubMed ID: 17516847
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-1 processes probiglycan.
Scott IC; Imamura Y; Pappano WN; Troedel JM; Recklies AD; Roughley PJ; Greenspan DS
J Biol Chem; 2000 Sep; 275(39):30504-11. PubMed ID: 10896944
[TBL] [Abstract][Full Text] [Related]
10. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
[TBL] [Abstract][Full Text] [Related]
11. Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.
Nguyen NQ; Tabruyn SP; Lins L; Lion M; Cornet AM; Lair F; Rentier-Delrue F; Brasseur R; Martial JA; Struman I
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14319-24. PubMed ID: 16973751
[TBL] [Abstract][Full Text] [Related]
12. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
Clapp C; Martial JA; Guzman RC; Rentier-Delure F; Weiner RI
Endocrinology; 1993 Sep; 133(3):1292-9. PubMed ID: 7689950
[TBL] [Abstract][Full Text] [Related]
13. Mammalian tolloid-like 1 binds procollagen C-proteinase enhancer protein 1 and differs from bone morphogenetic protein 1 in the functional roles of homologous protein domains.
Ge G; Zhang Y; Steiglitz BM; Greenspan DS
J Biol Chem; 2006 Apr; 281(16):10786-98. PubMed ID: 16507574
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis.
Ge G; Seo NS; Liang X; Hopkins DR; Höök M; Greenspan DS
J Biol Chem; 2004 Oct; 279(40):41626-33. PubMed ID: 15292192
[TBL] [Abstract][Full Text] [Related]
15. GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells.
Ge G; Hopkins DR; Ho WB; Greenspan DS
Mol Cell Biol; 2005 Jul; 25(14):5846-58. PubMed ID: 15988002
[TBL] [Abstract][Full Text] [Related]
16. Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells.
Galfione M; Luo W; Kim J; Hawke D; Kobayashi R; Clapp C; Yu-Lee LY; Lin SH
Protein Expr Purif; 2003 Apr; 28(2):252-8. PubMed ID: 12699689
[TBL] [Abstract][Full Text] [Related]
17. A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone.
Ueda E; Ozerdem U; Chen YH; Yao M; Huang KT; Sun H; Martins-Green M; Bartolini P; Walker AM
Endocr Relat Cancer; 2006 Mar; 13(1):95-111. PubMed ID: 16601282
[TBL] [Abstract][Full Text] [Related]
18. Structure and function of procollagen C-proteinase (mTolloid) domains determined by protease digestion, circular dichroism, binding to procollagen type I, and computer modeling.
Sieron AL; Tretiakova A; Jameson BA; Segall ML; Lund-Katz S; Khan MT; Li Sw; Stöcker W
Biochemistry; 2000 Mar; 39(12):3231-9. PubMed ID: 10727214
[TBL] [Abstract][Full Text] [Related]
19. The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin.
Clapp C; Torner L; Gutiérrez-Ospina G; Alcántara E; López-Gómez FJ; Nagano M; Kelly PA; Mejía S; Morales MA; Martínez de la Escalera G
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10384-8. PubMed ID: 7937959
[TBL] [Abstract][Full Text] [Related]
20. Sequence and expression of hamster prolactin and growth hormone messenger RNAs.
Southard JN; Sanchez-Jimenez F; Campbell GT; Talamantes F
Endocrinology; 1991 Dec; 129(6):2965-71. PubMed ID: 1954881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
